2448.6000 -25.00 (-1.01%)
NSE Jan 01, 2026 10:24 AM
Volume: 6,922
 

2448.60
-1.01%
Sharekhan
steady operating performance with revenue growing by ~8% (driven by 5.4% volume growth). Strong expansion in EBIDTA margins and higher other income led to strong bottom-line growth. Horlicks continued to maintain its leadership in the Health Food Drinks (HFD) category with 44% market share. Premium products gaining good traction coupled with new product launches and improving penetration will be key revenue drivers going ahead. The integration of GSK Consumer and Hindustan Unilever (HUL) will take place by...
Number of FII/FPI investors decreased from 390 to 362 in Sep 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended